Distribution of 18F-5-fluorouracil in tumor-bearing mice and rats.

[1]  D. Taylor,et al.  Comparative study on the effects of surgery, chemotherapy, and immunotherapy, alone and in combination, on metastases of the 13762 mammary adenocarcinoma. , 1974, Cancer research.

[2]  G. Ramírez,et al.  Adenocarcinomas of stomach, pancreas, liver, and biliary tracts. Survival of 328 patients treated with fluoropyrimidine therapy , 1974, Cancer.

[3]  J. Windheuser,et al.  5-Fluorouracil and derivatives in cancer chemotherapy. 3. In vivo enhancement of antitumor activity of 5-fluorouracil (FU) and 5-fluoro-2'-deoxyuridine (FUDR). , 1973, Journal of pharmaceutical sciences.

[4]  O. Frankfurt.  Enhancement of the antitumor activity of 5-fluorouracil by drug combinations. , 1973, Cancer research.

[5]  M. Chadwick,et al.  The physiological disposition of 5-fluorouracil in mice bearing solid L1210 lymphocytic leukemia. , 1972, Cancer research.

[6]  J. Holland,et al.  Comparison of treatment of metastatic gastrointestinal cancer with 5‐fluorouracil (5‐FU) to a combination of 5‐FU with cytosine arabinoside , 1972, Cancer.

[7]  L. G. Suhrland,et al.  Enhancement of tumor growth and immunosuppression in mice with 5- fluorouracil , 1972, The American journal of the medical sciences.

[8]  H. Morris,et al.  Further Studies of Electron Transport Components in a Series of Morris Hepatoma-Bearing Rats , 1972, British Journal of Cancer.

[9]  C. Heidelberger.  Chemical carcinogenesis, chemotherapy: cancer's continuing core challenges--G. H. A. Clowes Memorial Lecture. , 1970, Cancer research.

[10]  D. Hutchison,et al.  The physiologic disposition of 5‐fluorouracil and 5‐fluoro‐2′‐deoxyuridine in man , 1964, Clinical pharmacology and therapeutics.

[11]  E. G. Wollish,et al.  Thin-layer chromatography of fluoropyrimidines , 1964 .

[12]  C. Heidelberger,et al.  EXPERIMENTAL AND CLINICAL USE OF FLUORINATED PYRIMIDINES IN CANCER CHEMOTHERAPY. , 1963, Cancer research.

[13]  K. Sugiura.  THE EFFECT OF ACTINOMYCIN D ON A SPECTRUM OF TUMORS * , 1960 .

[14]  C. Heidelberger,et al.  Studies on Fluorinated Pyrimidines XI . In Vitro Studies on Tumor Resistance , 2006 .

[15]  C. Heidelberger,et al.  Studies on fluorinated pyrimidines. IX. The degradation of 5-fluorouracil-6-C14. , 1960, The Journal of biological chemistry.

[16]  C. Heidelberger,et al.  Studies on fluorinated pyrimidines: VII—the degradative pathway☆☆☆ , 1959 .

[17]  M. Potter,et al.  Response to cortisone and development of cortisone resistance in a cortisone-sensitive lymphosarcoma of the mouse. , 1958, Journal of the National Cancer Institute.

[18]  C. Heidelberger,et al.  Studies on fluorinated pyrimidines. III. The metabolism of 5-fluorouracil-2-C14 and 5-fluoroorotic-2-C14 acid in vivo. , 1958, Cancer research.

[19]  C. Heidelberger,et al.  Studies on fluorinated pyrimidines. II. Effects on transplanted tumors. , 1958, Cancer research.

[20]  A. Novikoff,et al.  A transplantable rat liver tumor induced by 4-dimethylaminoazobenzene. , 1957, Cancer research.

[21]  C. Heidelberger,et al.  The comparative utilization of uracil-2-C14 by liver, intestinal mucosa, and Flexner-Jobling carcinoma in the rat. , 1957, Cancer research.

[22]  C. Heidelberger,et al.  Fluorinated Pyrimidines, A New Class of Tumour-Inhibitory Compounds , 1957, Nature.

[23]  A. E. Moore,et al.  Heterologous growth of sarcoma 180 with progression to death of hosts. , 1950, Cancer research.

[24]  James B. Murphy,et al.  The Transmission of an Induced Lymphatic Leukemia and Lymphosarcoma in the Rat , 1941 .

[25]  J. Jacksén,et al.  The Value of a “Functional Test” in Selecting Material for a Genetic Study of Mammary Tumors in Mice and Rats , 1937 .

[26]  W. Earle.  A Study of the Walker Rat Mammary Carcinoma 256, in vivo and in vitro , 1935 .

[27]  A. Wolf,et al.  The synthesis of 18 F-5-fluorouracil. VII. , 1973, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[28]  C. Heidelberger,et al.  Studies on Fluorinated Pyrimidines XVI. Metabolism of 5-Fluorouracil-2-C14 and 5-Fluoro-2′-deoxyuridine-2-C14 in Cancer Patients , 1963 .

[29]  C. Heidelberger,et al.  Studies on Fluorinated Pyrimidines XVII. Tissue Distribution of 5-Fluorouracil-2-C14 and 5-Fluoro-2′-deoxyuridine in Cancer Patients , 1963 .